Abstract
The postoperative survival in 554 lung carcinomata, classified according to the histologic type, was calculated by the actuarial method. On the whole, squamous cell carcinoma was the most favourable and anaplastic small cell carcinoma the least favourable lesion. However, in tumors smaller than 4 cm, confined to the lung and with negative lymph nodes (stage I), small cell carcinoma had the highest percentage of 5 yr survivors, followed by large cell carcinoma, squamous cell carcinoma and adenocarcinoma. When tumors had attained a larger size and/or spread to neighbouring structures and regional lymph nodes (stage II and III), the histologic type was a much more determining factor in survival, squamous cell carcinoma being a significantly more favourable lesion. On the other hand, no difference in survival in relation to the histologic type was found when distant metastases were probably present (stage IV). It was concluded that in assessing the role of histopathology in the prognosis of lung cancer, the mutual relation to other pathologic factors must be taken into account.
| Original language | English |
|---|---|
| Pages (from-to) | 240-246 |
| Number of pages | 7 |
| Journal | British Journal of Cancer |
| Volume | 29 |
| Issue number | 3 |
| Publication status | Published - 1974 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Survival rates of lung cancer according to histological type. / Campobasso, O.; Invernizzi, B.; Musso, M.; Berrino, F.
In: British Journal of Cancer, Vol. 29, No. 3, 1974, p. 240-246.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Survival rates of lung cancer according to histological type
AU - Campobasso, O.
AU - Invernizzi, B.
AU - Musso, M.
AU - Berrino, F.
PY - 1974
Y1 - 1974
N2 - The postoperative survival in 554 lung carcinomata, classified according to the histologic type, was calculated by the actuarial method. On the whole, squamous cell carcinoma was the most favourable and anaplastic small cell carcinoma the least favourable lesion. However, in tumors smaller than 4 cm, confined to the lung and with negative lymph nodes (stage I), small cell carcinoma had the highest percentage of 5 yr survivors, followed by large cell carcinoma, squamous cell carcinoma and adenocarcinoma. When tumors had attained a larger size and/or spread to neighbouring structures and regional lymph nodes (stage II and III), the histologic type was a much more determining factor in survival, squamous cell carcinoma being a significantly more favourable lesion. On the other hand, no difference in survival in relation to the histologic type was found when distant metastases were probably present (stage IV). It was concluded that in assessing the role of histopathology in the prognosis of lung cancer, the mutual relation to other pathologic factors must be taken into account.
AB - The postoperative survival in 554 lung carcinomata, classified according to the histologic type, was calculated by the actuarial method. On the whole, squamous cell carcinoma was the most favourable and anaplastic small cell carcinoma the least favourable lesion. However, in tumors smaller than 4 cm, confined to the lung and with negative lymph nodes (stage I), small cell carcinoma had the highest percentage of 5 yr survivors, followed by large cell carcinoma, squamous cell carcinoma and adenocarcinoma. When tumors had attained a larger size and/or spread to neighbouring structures and regional lymph nodes (stage II and III), the histologic type was a much more determining factor in survival, squamous cell carcinoma being a significantly more favourable lesion. On the other hand, no difference in survival in relation to the histologic type was found when distant metastases were probably present (stage IV). It was concluded that in assessing the role of histopathology in the prognosis of lung cancer, the mutual relation to other pathologic factors must be taken into account.
UR - http://www.scopus.com/inward/record.url?scp=0016364329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016364329&partnerID=8YFLogxK
M3 - Article
C2 - 4364383
AN - SCOPUS:0016364329
VL - 29
SP - 240
EP - 246
JO - British Journal of Cancer
JF - British Journal of Cancer
SN - 0007-0920
IS - 3
ER -